Class 514/560 - Carbon to carbon unsaturation

Subclass of Class 514 - Drug, bio-affecting and body treating compositions
Definition: Subject matter wherein the chain of at least seven carbon
No. of patents: 784
Last issue date: 05/29/2012

«First «Previous1 2 3 4 5 6 7 8 9 10 11 Next»Last»

Number	Title	Issue Date
8188146	Highly purified ethyl EPA and other EPA derivatives A pharmaceutical preparation comprising EPA in an appropriately assimilable form where of all the fatty acids present in the preparation at least 90%, and preferably at least 95%, is in the form of EPA and where less than 5%, and preferably less than 3%, is in the f...	05/29/2012
8153691	Method for preparing compositions for preventing or treating inflammatory bowel disease A method for preparing compositions, comprising docosahexaenoic acid (DHA) and optionally one or more fatty acids selected from the group consisting of eicosapentaenoic acid (EPA), arachidonic acid (ARA), linoleic acid (LA), and α-linoleic acid (ALA), that are admi...	04/10/2012
8143309	Methods and composition for treating a material A composition and method are described for sanitizing or otherwise treating a material such as a non-living surface, living tissue, soil or atmosphere which may be contaminated by a toxin, chemical warfare agent, insect, prion, microorganism or other infectious agen...	03/27/2012
8143310	Reduction of sterols and other compounds from oils A process for the removal of sterols, specifically cholesterol, from a triglyceride oil, preferably a marine triglyceride oil, said process comprising contacting an oil with an adsorbent, specifically TRIS YL™, clay or a mixture thereof, heating the mixture to 100...	03/27/2012
8071646	Omega 3 fatty acid formulations The present invention provides highly purified omega-3 fatty acid formulations. Certain formulations provided herein contain greater than 85% omega-3 fatty acids by weight. Certain other formulations provided herein contain EPA and DHA in a ratio of from about 4.01:...	12/06/2011
8067470	Linoleic acid preparations for the topical treatment of male and female pattern androgenetic alopecia, age-related alopecia, and keratosis pilaris A preparation for the topical application of linoleic acid to treat male and female androgenetic alopecia, age-related alopecia, and keratosis pilaris contains between about 0.1% and about 10%, preferably between about 1% and about 5%, and specifically about 2% lino...	11/29/2011
8053473	Antibacterial agent comprising 7, 10-dihydroxy-8(E)-octadecenoic acid The present invention relates to an antibacterial agent containing 7,10-dihydroxy-8(E)-octadecenoic acid (referred as DOD) as an active ingredient. DOD produced by the method of the present invention can be effectively used as an antibacterial agent because it has a...	11/08/2011
8048922	Compositions and methods for treating feline inflammatory bowel disease Compositions comprising eicosapentaenoic acid and docosahexaenoic acid in a ratio of from 1.2 to 2 are administered to felines to treat feline inflammatory bowel disease. ...	11/01/2011
8034842	Compounds Compounds of formula (I); wherein R1 and R2 are the same or different and may be selected from the group consisting of a hydrogen atom, a hydroxy group, an alkyl grou...	10/11/2011
8034841	Method for placental exfoliation using oxo-arachidonic acid or the like A composition for placental exfoliation and a method for placental exfoliation. The composition for placental exfoliation contains an arachidonic acid derivative or the like, and the method for placental exfoliation comprises the step of administering an arachidonic...	10/11/2011
8017652	Activators of peroxisome proliferator-activated receptors Activators of peroxisome proliferator-activated receptors comprising a polyprenyl compound, preferably (2E,4E,6E,10E)-3,7,11,15-tetramethyl-2,4,6,10,14 -hexadecapentaenoic acid, as an active ingredient, and medicaments for preventive and/or therapeutic treatment of ...	09/13/2011
8017653	Bipolar trans carotenoid salts and their uses The invention relates to trans carotenoid salt compounds, methods for making them, methods for solubilizing them and uses thereof. These compounds are useful in improving diffusivity of oxygen between red blood cells and body tissues in mammals including humans....	09/13/2011
7964641	Treatment of neurodegenerative conditions A method is provided for treating a patient in need of therapy for a neurodegenerative disease comprising administering to that patient a therapeutically effective dose of a lipid glyceride comprising a glycerol moiety and a fatty acid moiety, the fatty acid moiety ...	06/21/2011
7947737	Method of treating hypertension and reducing serum lipase activity This invention relates to a method of treating hypertension and reducing serum lipase activity by dietary supplementation with conjugated linoleic acid. The method comprises administering a safe and effective amount of conjugated linoleic acid to a human. The conjug...	05/24/2011
7935730	Method of enhancing reproductive function of mammals by feeding of conjugated linoleic acids This invention provides methods for improving reproductive performance of lactating dairy cows and other mammals. The method in the case of cows comprises feeding to the cows, a composition comprising conjugated linoleic acids (CLAs), cis-9, trans-11 and trans-10, c...	05/03/2011
7915313	Inhibitors of yeast filamentous growth and method of their manufacture The invention broadly relates to the use of α,β-unsaturated fatty acids to inhibit the filamentous growth of fungi and yeasts and to a method for producing same. In particular the invention relates to the use of optionally substituted C8 to C15 α,β-unsaturated f...	03/29/2011
7842727	Histone deacetylase inhibitors Histone deacetylase is a metallo-enzyme with zinc at the active site. Compounds having a zinc-binding moiety, such as, for example, a hydroxamic acid group or a carboxylic acid group, can inhibit histone deacetylase. Histone deacetylase inhibition can repress gene e...	11/30/2010
7767713	Linoleic acid active agents for enhancing probability of becoming pregnant The present invention is directed to a methods and compositions for enhancing the probability that a subject will become pregnant. The method comprises administering to a subject a pharmaceutical composition comprising an effective amount of a linoleic acid active a...	08/03/2010
7759395	Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma The present invention is generally drawn to novel isolated therapeutic agents, termed resolvins, generated from the interaction between a dietary omega-3 polyunsaturated fatty acid (PUFA) such as eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA), cyclooxygen...	07/20/2010
7754766	Methods and composition for treating a material A composition and method are described for sanitizing or otherwise treating a material such as a non-living surface, living tissue, soil or atmosphere which may be contaminated by a toxin, chemical warfare agent, insect, prion, microorganism or other infectious agen...	07/13/2010
7741369	Lipoxin compounds and their use in treating cell proliferative disorders Compounds having the active site of natural lipoxins, but a longer tissue half-life are disclosed. In particular, 15-epi-lipoxins and their use in ameliorating undesired cell proliferation, which characterizes diseases such as cancer, are also disclosed. ...	06/22/2010
7741368	Approach to antimicrobial host defense with molecular shields with EPA and DHA analogs Methods to cause tissue, such as mucosal cells, to express increased amounts of bactericidal permeability increasing protein (BPI) are described. Various BPI inducing agents include icosapentanoic acid (EPA) analogs and docosahexaenoic acid (DHA) analogs. ...	06/22/2010
7737178	Aspirin-triggered lipid mediators Aspirin triggered lipid mediators (ATLMs) are disclosed which are useful for the treatment of prevention of inflammation associated with various diseases, including ischemia. ...	06/15/2010
7723388	Avian appeasing pheromones to decrease stress, anxiety and aggressiveness Compositions comprising a mixture of fatty acids or derivatives thereof derived from secretions of the uropygial glands of birds are disclosed. This composition, named an avian appeasing pheromone, can be used to decrease stress, anxiety and agressiveness in birds.	05/25/2010
7718699	Abscissic acid and derivatives thereof for the treatment of diseases The present invention relates generally to the fields of molecular biology and pharmacology. More particularly, it concerns the use of abscissic acid to treat various diseases, including neurodegenerative diseases and neuromuscular diseases. ...	05/18/2010
7691906	High lipid diet A composition for use as a medicament, functional food or nutritional product is described which comprises at least one lipid wherein the lipid provides greater than 35% total energy of the composition. A preferred embodiment comprises a n-6/n-3 fatty acid ratio of ...	04/06/2010
7687543	Use of polyunsaturated ketones for the treatment of psoriasis Psoriasis is a common, chronic, inflammatory skin disorder. This invention provides the use of a compound of formula (I) R—CO—X (Wherein R is a C16-24 unsaturated hydrocarbon group optionally interrupted α, β, γ, or δ to the carbonyl group by a he...	03/30/2010
7666910	Method of stabilizing and potentiating the action of anti-angiogenic substances A method of stabilizing and potentiating action of molecules of known anti-angiogenic substances such as ANGIOSTATIN® or ENDOSTATIN® by using in coupling conjugation with cis-unsaturated fatty acids (c-UFAs) in the treatment of cell proliferative disorders uses c-...	02/23/2010
7652068	Omega 3 fatty acid formulations The present invention provides highly purified omega-3 fatty acid formulations. Certain formulations provided herein have contain greater than 85% omega-3 fatty acids by weight. Certain other formulations provided herein contain EPA and DHA in a ratio of from about ...	01/26/2010
7560486	Composition and method for modifying the fatty acid composition of cell membranes of organs and tissues The present invention relates to a composition and method for rapidly modifying the fatty acid composition of cell membranes of organs and tissues, in particular to increase the amount of omega-3 fatty acids of cell membranes of organs and tissues by parenterally ad...	07/14/2009
7547730	Activators of peroxisome proliferator-activated receptors Activators of peroxisome proliferator-activated receptors comprising a polyprenyl compound, preferably (2E,4E,6E,10E)-3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid, as an active ingredient, and medicaments for preventive and/or therapeutic treatment of h...	06/16/2009
7531574	Method of enhancing reproductive function of mammals by feeding of conjugated linoleic acids This invention provides methods for improving reproductive performance of lactating dairy cows and other mammals. The method in the case of cows comprises feeding to the cows, a composition comprising conjugated linoleic acids (CLAs), cis-9, trans-11 and trans-10, c...	05/12/2009
7514472	Fat or oil composition Described is a fat or oil composition which comprises at least 35 wt % of a diacylglycerol, the constituent fatty acids of said diacylglycerol satisfying the following equation: (an amount of a cis-form unsaturated fatty acid)/(an amount of a saturated fatty acid+an...	04/07/2009
7473708	Agents with leukotriene B-like antiviral (enveloped RNA) activities The present invention relates to the use of the antiviral activity of exogenous leukotriene B4 (LTB4), variants and derivatives thereof as a therapeutic agent in viral infections caused by human and animal enveloped RNA viruses. The human and a...	01/06/2009
7439267	Essential n-3 fatty acids in cardiac insufficiency and heart failure therapy The present invention concerns a method of therapeutic prevention and treatment of a heart disease chosen from cardiac insufficiency and heart failure including the administration of an essential fatty acid containing a mixture of eicosapentaenoic acid ethyl ester (...	10/21/2008
7413759	Method of enhancing cognitive ability in infant fed DHA containing baby-food compositions Methods for enhancing cognitive ability in infants are shown. The methods comprise feeding infants baby-food compositions containing docosahexaenoic acid (DHA) in an amount of at least about 0.5 mg per gram of the composition. Infants fed a composition containing DH...	08/19/2008
7414077	Therapeutic intervention to mimic the effect of caloric restriction Methods are provided for promoting longevity and decreasing the incidence of ageing associated pathologies (e.g. cancer) by the administration of one or more of the following LFFA: linoleic, oleic, and palmitic acid. Secondary LFFA derived from this set, as well as ...	08/19/2008
7378443	Fatty acid analogues for the treatment of cancer A fatty acid analogue of the general formula: R1-[xi-CH2]n—COOR2, wherein R1 is: a C2-C24 alkene with one or more double bonds and/or with one or more triple bonds, and/or a C	05/27/2008
7378444	Analogues of lipid mediators derived from omega-3 PUFAs and methods of use The present invention is directed to compounds that are analogues of lipid mediators derived from a fish oil-derived fatty acid, eicosapentaenoic acid [C20:5 ω-3; EPA], but with a longer tissue half-life and enhanced bioactivity. These analogues may be used to trea...	05/27/2008
7358278	Cellular phosphorylation potential enhancing compositions preparation and use thereof A pharmaceutical composition comprising as an active phosphorylation potential enhancing substance a pharmaceutically-acceptable salt of an alpha-keto carboxylic acid thereof alone or in combination with nicatinamide and creatine and, its use and products containing...	04/15/2008

«First «Previous1 2 3 4 5 6 7 8 9 10 11 Next»Last»

PatentStorm

Quotables

PatentStorm News

Class 514/560 - Carbon to carbon unsaturation